Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 2, 2012, Pages 197-203

  Koller, Tomas ^a   Kollerova, Jana ^a   Hlavaty, Tibor ^a   Huorka, Martin ^a   Payer, Juraj ^a  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Biliary clinical; Hepatobiliary clinical

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHOLECYSTECTOMY; CHOLELITHIASIS; ECHOGRAPHY; FEMALE; GALLSTONE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLELITHIASIS; CHOLESTEROL; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; RISK FACTORS; TRIGLYCERIDES;

EID: 84856025741     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.643481     Document Type: Article

References (18)

1. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006;368:230-9.
2. Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006;20: 981-96. (Pubitemid 44793722)
3. Tsai CHJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr 2004;80:38-44. (Pubitemid 41115552)
4. Pagliarulo M, Fornari F, Fraquelli M, Zoli M, Giangregorio F, Grigolon A, et al. Gallstone disease and related risk factors in a large cohort of diabetic patients. Dig Liver Dis 2004;36:130-4. (Pubitemid 41115507)
5. Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr 2004;80:1-2. (Pubitemid 41115546)
6. Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez Baptista H, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005;11:1653-7. (Pubitemid 40520807)
7. Koller T, Kollerová J, Hlavatý T, Huorka M, Payer J. Prevalence of liver disease markers among patients with metabolic risk factors. Vnitr Lek 2010;56:183-9.
8. deAlwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008;48(Suppl 1):S104-12.
9. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008;51:1947-53.
10. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372-84.
11. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007;13:1579-84. (Pubitemid 46672668)
12. Ramos-De la Medina A, Remes-Troche JM, Roesch- Dietlen FB, Pérez-Morales AG, Martinez S, Cid-Juarez S. Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? J Gastrointest Surg 2008;12:2097-102.
13. Ioannou GN. Cholelithiasis. cholecystectomy. and liver disease. Am J Gastroenterol 2010;105:1364-73.
14. Loria P, Lonardo A, Lombardini S, Carulli L, Verrone A, Ganazzi D, et al. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 2005;20:1176-84. (Pubitemid 41602559)
15. Fraenkel E, Takács R, Hamvas J, Lengyel G, Fehér J. Common occurrence ofnon-alcoholic fatty liver disease and cholecystolithiasis. Orv Hetil 2007;148:793-8. (Pubitemid 47490100)
16. Kovacs P, Kurtz U, Wittenburg H. Hepatic insulin resistance ties cholesterol gallstone formation and the metabolic syndrome. Annals of Hepatology. 2008;7:262-4.
17. Yang ZX, Shen W, Sun H. Effects of nuclear receptor FXR on the regulation of the liver lipid metabolism in patients with non-alcoholic fatty liver disease. Hepatol Int 2010;4:741-8.
18. Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholicfatty liver disease and metabolic syndrome. J Dig Dis 2011;12:125-30.